Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Revatio (sildenafil citrate) - Important Safety Information from Pfizer Healthcare Ireland as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
04/10/2011
Problem Or Issue:
Important Safety Information relating to increased risk of mortality in paediatric patients with pulmonary arterial hypertension with the use of higher than recommended doses of Revatio (sildenafil citrate).
Pfizer Revatio DHPC 04.09.11.pdf
« Back
Date Printed: 16/05/2024